B2B vs B2C Peptide Payment Processing: Why Wholesale Rates Run Lower

What are the rate ranges, and what sits behind each one?

Why do banks treat wholesale and retail peptide sales differently?

You can see the split in a large processor’s public rules. Adyen’s restricted and prohibited list names “peptides, research chemicals” in its hazardous materials line. It marks B2B sales of those products restricted, which means extra review. It marks B2C sales prohibited.

The regulatory risk also sits mostly on the consumer side. FDA warning letters to online peptide sellers dated March 31, 2026 and August 24, 2026 were built on what those public websites said and sold, not on the label alone. A bank that boards a retail store is betting on that website staying clean.

Then there are disputes. Cardholders have dispute rights under federal law, explained in the FTC’s guide to credit card disputes. A lab with a standing account, a purchase order and an invoice has every reason to call the supplier before it calls the bank. A one-time buyer on a public checkout may not. Dispute exposure is part of what the bank prices.

What counts as a B2B buyer?

A business or institution buying for its own research or for resale, with a paper trail that shows it. In practice that means:

• Research labs, universities and other institutions ordering on account or by purchase order
• Resellers and distributors with their own business details on file
• Repeat orders tied to a named business, not a personal email address
• Invoices and agreements you can hand an underwriter

A store that sells mostly to individuals through a public checkout is retail, even if it calls itself wholesale or puts a quantity discount on the page. Underwriters check the buyer list, not the label on the program.

Are clinics and med spas safe B2B buyers?

Not in our view, and one state regulator has said why. Ohio Board of Pharmacy guidance, Ten Common Prescriber Clinic and Medical Spa Violations (updated December 8, 2025), says no clinic “should order, possess, or administer any drugs labeled ‘for research purposes only’.” It says such products are unlawful for prescriber clinics and med spas to possess, and that any on hand “must be disposed of immediately.” As of that update, the Board said it had summarily suspended more than 30 clinics and med spas since the beginning of 2025.

For a supplier, that means a clinic account is not a low-risk business buyer. It is a buyer that may be breaking state rules by owning the product. Selling into that channel puts your own account at risk, whatever the invoice says.

What does wholesale underwriting usually ask for?

• Representative buyer agreements or invoices
• Supplier agreements and certificates of analysis
• Several months of processing and bank statements, where available

Deeper files take more work up front. They are also what lets a bank price a wholesale supplier at the lower range.

What if I sell both wholesale and retail?

Tell us the split up front. Wholesale and retail are reviewed and priced separately, and the acquiring bank decides how a mixed business is set up. Do not route retail orders through a wholesale account to get the lower range. That is a mismatch between the account and the activity, the same mismatch we describe in our post on MCC miscoding.

If most of your volume is retail, the work that matters is the site itself. Our compliance guide and the Stripe policy breakdown cover what underwriters read on a retail store. You can also see how we work.

Sources

1. List of restricted and prohibited products and services, Adyen, read Oct 26, 2026.
2. Ten Common Prescriber Clinic and Medical Spa Violations, Ohio Board of Pharmacy, updated Dec 8, 2025.
3. Warning letter to an online peptide seller, US FDA, Mar 31, 2026.
4. Warning letter to an online peptide seller, US FDA, Aug 24, 2026.
5. Using Credit Cards and Disputing Charges, US Federal Trade Commission, read Oct 26, 2026.